The estimated Net Worth of Henry A Mckinnell is at least $35.2 Million dollars as of 20 May 2022. Henry Mckinnell owns over 7,726 units of Moody`s stock worth over $34,816,944 and over the last 21 years he sold MCO stock worth over $0. In addition, he makes $414,955 as Independent Chairman of the Board at Moody`s.
Sign up
Henry McKinnell MCO stock SEC Form 4 insiders trading
Henry has made over 9 trades of the Moody`s stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 7,726 units of MCO stock worth $3,697,586 on 20 May 2022.
The largest trade he's ever made was buying 334,728 units of Moody`s stock on 22 August 2016 worth over $987,448. On average, Henry trades about 4,880 units every 36 days since 2003. As of 20 May 2022 he still owns at least 72,749 units of Moody`s stock.
You can see the complete history of Henry Mckinnell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Henry McKinnell biography
Dr. Henry A. McKinnell Jr., Ph.D. has been appointed as Independent Director of the Company effective 12/31/2020. Dr. McKinnell served as the Chief Executive Officer of Optimer Pharmaceuticals, Inc. from February 2013 until October 31, 2013. He served as Chairman of the Board of Pfizer Inc., a pharmaceutical company, from May 2001 until his retirement in December 2006 and Chief Executive Officer from January 2001 to July 2006. He served as President of Pfizer Inc. from May 1999 to May 2001, and as President of Pfizer Pharmaceuticals Group from January 1997 to April 2001. Dr. McKinnell served as Chief Operating Officer of Pfizer Inc. from May 1999 to December 2000 and as Executive Vice President from 1992 to 1999. He served as the Chairman of the Accordia Global Health Foundation, is Chairman Emeritus of the Connecticut Science Center and is Life Director of the Japan Society. He currently serves as a director of ChemoCentryx, Inc. He served as Chairman of Optimer Pharmaceuticals, Inc. until 2013 and Emmaus Life Sciences until 2015. He served as a director of Angiotech Pharmaceuticals, Inc. until 2011, Pfizer Inc. and ExxonMobil Corporation until 2007 and John Wiley & Sons until 2005. He also served as a director of ViewRay, Inc. from April 2016 to May 2019. Dr. McKinnell served for five years as the chief executive officer of a public pharmaceutical company with worldwide operations and, prior to that position, served as president, chief operating officer, chief financial officer and executive vice president. As a result of these positions, Dr. McKinnell brings to the Board financial expertise, global management experience and leadership skills. In addition, because the pharmaceutical business, like the Company’s, operates in a highly regulated industry, Dr. McKinnell brings to the Board an appreciation of what a complex regulatory environment means for the Company’s operations. Dr. McKinnell has also served as a director of several public companies, contributing to his perspective on corporate governance matter
What is the salary of Henry McKinnell?
As the Independent Chairman of the Board of Moody`s, the total compensation of Henry McKinnell at Moody`s is $414,955. There are 9 executives at Moody`s getting paid more, with Raymond McDaniel having the highest compensation of $13,751,600.
How old is Henry McKinnell?
Henry McKinnell is 77, he's been the Independent Chairman of the Board of Moody`s since 2012. There are no older and 21 younger executives at Moody`s.
What's Henry McKinnell's mailing address?
Henry's mailing address filed with the SEC is C/O CHEMOCENTRYX, INC., 835 INDUSTRIAL ROAD, SUITE 600, SAN CARLOS, CA, 94070.
Insiders trading at Moody`s
Over the last 21 years, insiders at Moody`s have traded over $878,420,300 worth of Moody`s stock and bought 8,915 units worth $547,914 . The most active insiders traders include Hathaway Incbuffett Warren ..., Corp /De/ Moodys, and Hathaway Incbuffett Warren .... On average, Moody`s executives and independent directors trade stock every 21 days with the average trade being worth of $38,079,013. The most recent stock trade was executed by Stephen T Tulenko on 9 August 2024, trading 500 units of MCO stock currently worth $232,030.
What does Moody`s do?
moody's is an essential component of the global capital markets, providing credit ratings, research, tools and analysis that contribute to transparent and integrated financial markets. moody's corporation (nyse: mco) is the parent company of moody's investors service, which provides credit ratings and research covering debt instruments and securities, and moody's analytics, which offers leading-edge software, advisory services and research for credit and economic analysis and financial risk management. the corporation, which reported revenue of $3.3 billion in 2014, employs approximately 9,900 people worldwide and maintains a presence in 33 countries. further information is available at www.moodys.com.
What does Moody`s's logo look like?
Complete history of Henry Mckinnell stock trades at ChemoCentryx Inc, ViewRay, Exxon Mobil, and Moody`s
Moody`s executives and stock owners
Moody`s executives and other stock owners filed with the SEC include:
-
Raymond McDaniel,
President, Chief Executive Officer, Director -
Robert Fauber,
Chief Operating Officer, Executive Vice President, Director -
John Goggins,
Executive Vice President, General Counsel -
Mark Kaye,
Chief Financial Officer, Senior Vice President -
Stephen Tulenko,
President - Moody’s Analytics -
Robert Scott Fauber,
Pres, CEO & Director -
Mark Bradley Kaye,
Sr. VP & CFO -
Michael L. West,
Pres of Moody's Investors Service Inc. -
Stephen T. Tulenko,
Pres of Moody's Analytics -
Henry McKinnell,
Independent Chairman of the Board -
Leslie Seidman,
Independent Director -
Kathryn Hill,
Independent Director -
Basil Anderson,
Independent Director -
Therese Esperdy,
Independent Director -
Bruce Van Saun,
Independent Director -
Vincent Forlenza,
Independent Director -
Jorge Bermudez,
Independent Director -
Michael West,
President - Moody’s Investors Service -
Caroline Sullivan,
Senior Vice President, Corporate Controller -
Melanie Hughes,
Chief Human Resource Officer, Senior Vice President -
Michael Adler,
Sr. VP of Corp. Communications -
Helene Gurian,
Chief Compliance Officer -
John J. Goggins,
Exec. VP & Gen. Counsel -
Shivani Kak,
Head of Investor Relations -
Mona Breed,
Sr. VP & Chief Information Officer -
Caroline Dolores Sullivan,
Chief Accounting Officer, Sr. VP & Corp. Controller -
Richard G Steele,
SVP - General Counsel -
Jose Minaya,
Director -
Linda Huber,
Executive VP and CFO -
Richard Cantor,
Chief Risk Officer -
Michael S Crimmins,
SVP-Corporate Controller -
Ewald Kist,
Director -
Blair Worrall,
SVP-Ratings Delivery and Data -
Lisa Westlake,
Chief Human Resources Officer -
Darrell Duffie,
Director -
Mark Almeida,
President, Moody's Analytics -
Hathaway Incbuffett Warren ...,
-
Lloyd Jr Howell,
Director -
Gerrit Zalm,
Director -
Nancy Newcomb,
Director -
Brian Clarkson,
Pres, Moody's Investors Svcs -
Jeanne Dering,
Executive VP -
Chester V Murray,
Senior Vice President -
Jennifer Elliott,
VP - Human Resources -
John Jr Rutherfurd,
Chairman and CEO -
Mary Johnston Evans,
Director -
Hathaway Incobh Llcbuffett ...,
-
Douglas M Woodham,
Senior Vice President -
Judith Vance,
Senior Vice President -
Hathaway Incbuffett Warren ...,
-
Charles Bruschi,
Vice President, Controller -
Perry Rotella,
SVP Chief Information Officer -
Andrew Kriegler,
Senior Vice President -
Hall Jr Adams,
Director -
Hathaway Incbuffett Warren ...,
-
Cornelius Iii Mcgillicudy,
Director -
Clifford L Jr Alexander,
Director -
Joseph J Mccabe,
Senior Vice President -
Michel Madelain,
Chief Operating Officer-MIS -
John K Wulff,
Director -
Robert R Glauber,
Director -
Zig Serafin,
Director -
Noemie Clemence Heuland,
SVP & Chief Financial Officer -
Corp /De/ Moodys,
Director